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Abstract
Background: Oral administration of probiotics is known to modulate cytokines profile not only locally, but also
systemically. Four strains of Lactobacillus salivarius, LDR0723, BNL1059, RGS1746 and CRL1528, were evaluated for
their ability to modulate release of pro- and anti-inflammatory cytokines.
Findings: Strains were assessed for effects on production of Interleukin-12 (IL-12), Interferon-g (IFN-g), Interleukin-4
(IL-4) and Interleukin-5 (IL-5) by incubating bacterial suspensions with THP-1 macrophage like cells. Cytokines were
determined by means of specific quantitative enzyme-linked immunosorbent assays.
LDR0723 and CRL1528 led to a sustained increment in production of IL-12 and IFN-g and to a decrease in release
of IL-4 and IL-5, while BNL1059 and RGS1746 favoured Th2 response, leading to a decrease in Th1/Th2 ratio with
respect to unstimulated cells.
Conclusions: In conclusion, capability of L. salivarius to modulate immune response was strictly strain dependent
and strains of the same species might have opposite effects. Therefore, a careful evaluation of anti-inflammatory
properties of lactobacilli should be performed on single strain, before any consideration on potential probiotic use.
Findings
Oral administration of lactobacilli may modulate cyto-
kines profile not only at intestinal level but also systemi-
cally [1]. The main difference between the mucosal and
systemic immunities is that in the former the mechan-
isms of innate immunity and the activation of B cells for
mucosal immunity are more important than the adap-
tive immune response involving the T cell population.
At the gut mucosal level, the innate immune response
provides the first line of defence against pathogenic
microorganisms which is initiated by immunoglobulin A
(IgA) secretion. Studies with animal models have shown
that intestinal microorganisms increase the numbers of
IgA-secreting plasma cells, thus up-regulating IgA secre-
tion, although the precise mechanisms underlying the
way these bacteria modulate the intestinal immune sys-
tem still remain unclear. Interactions among antigen-
presenting cells (APCs) naïve T cells and B cells lead to
generation of B cells with a high level of IgA expression.
Ag-activated T and B cells may migrate from the induc-
tive environment to effector sites through lymphatic
drainage and blood-stream. Multiple cytokines, includ-
ing TGF-b and IL-4, IL-5, IL-6 and IL-10 are required
to promote IgA class switching and maturation [2].
Cytokines produced by immunocompetent cells such
as APCs and T lymphocytes have been advocated to play
a significant role in several diseases, such as inflamma-
tory bowel disease (IBD), irritable bowel syndrome (IBS)
and allergies. Crohn’s disease and ulcerative colitis, the
major forms of IBD in humans are associated with exag-
gerated and poorly controlled Th1 or Th2 responses,
respectively, and with a more complex networks of cyto-
kine interactions, involving Th17 [3].
Lactobacilli have been shown to activate monocytes
and macrophages, which play a pivotal role in antigen
processing, presentation and activation of antigen-speci-
fic immunity and to stimulate IgA immunity. In particu-
lar, these cells together with dendritic and T regulatory
cells are essential in the deviation of immune response
to the so called type 1 response with cytotoxic effector
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cells or towards type 2 response characterized by anti-
body response. Type 2 response is related to secretion
of IL-4, IL-5, IL-9 and IL-13 which promote induction
of IgE and allergic response.
Effects of lactobacilli on host immune systems are
known to depend on the bacterial species involved,
since different strains are able to stimulate release of dif-
ferent cytokines. Results pointing toward stimulation of
both Th1 and Th2 responses have been observed in ani-
mals fed with probiotics while few or no data are avail-
able on strains of human origin [4].
Aim of this study was to in vitro evaluate the release
of pro- and anti-inflammatory cytokines induced by four
strains of Lactobacillus salivarius of human origin.
Bacterial strains and cell cultures
Lactobacillus salivarius strains LDR0723, BNL1059,
RGS1746 and CRL1528 were isolated from vaginal
brushing or faeces of four different apparently healthy
subjects, who declare to have not consumed probiotic
containing products in the two weeks preceeding sample
collection. Samples were plated on homofermentative-
heterofermentative differential (HHD) agar and incu-
bated for 48-72 h in anaerobiosis.
Lactobacilli strains were initially identified by means
of a biochemical assay based on carbohydrate fermenta-
tion (API50 CHL, BioMerieux Marcy L’Etoile, France).
Identification of L. salivarius strains was further con-
firmed by PCR, as described by Chaugnaud et al [5].
Lactobacilli were stored at -80°C in MRS broth sup-
plemented with 10% of glycerol until use.
Before experiments, bacteria were thawed and grown
on MRS agar plates at 37°C in 10% CO2 enriched atmo-
sphere for 24 h for two times and then subcultured in
MRS broth for 24 h at 37°C in 10% CO2 enriched
atmosphere.
The human macrophage-like cell line THP-1 (Istituto
Zooprofilattico Brescia, Italy) was grown in culture
flasks in RPMI-1640 medium (Sigma - Aldrich, Milan,
Italy) enriched with 10% heat-inactivated foetal bovine
serum (Sigma-Aldrich), 0.05 mM b-mercaptoethanol
(Sigma-Aldrich), 1% Na-pyruvate (Sigma-Aldrich), 1%
glutamine (Sigma-Aldrich) and 1% penicillin/streptomy-
cin (Sigma-Aldrich). Cells were incubated at 37°C in a
humified atmosphere containing 5% CO2.
Stimulation of THP-1 cells with lactobacilli
Overnight bacterial cultures were washed twice with
phosphate buffered saline buffer (PBS), pH 7.2, before
being resuspended at a concentration of about 2 × 109
CFU/ml
Ten microliters of each bacterial suspension were
transferred into the wells of a 24-wells plate containing
2 × 106 THP-1 cells/mL, and incubated at 37°C in a 5%
CO2/95% air atmosphere. After 24 h incubation, the
supernatant was aspirated, centrifuged at 2000 rpm and
stored at -20°C. Cells receiving PBS only were used as
unstimulated control. Each test was performed in tripli-
cate. Vitality of L. salivarius strains, evaluated by means
of growth curves, was not affected by incubation in
RPMI-1640 medium. No notable changes in THP-1 cells
counts were observed after incubation with L. salivarius
with respect cells receiving only PBS.
Production of IL-12, IFN-g, IL-4 and IL-5 was deter-
mined by means of specific quantitative enzyme-linked
immunosorbent assays (ELISA) (BenderMedSystems,
Wien, A), according to the manufacturer’s instructions.
Absorbance was measured at 450 nm using a Biorad
spectrophotometer (mod 680 Biorad, Segrate, Italy). For
each cytokine a standard curve was constructed in
duplicate and used to quantify amount of cytokine (pg)
per mL of culture medium. Ratio between Th1 and Th2
response was calculated as ratio between concentrations
of Th1 cytokines (IL-12 + IFN-g) and Th2 interleukins
(IL-4 + IL-5).
Results were reported as differences (%) vs unstimu-
lated cells of three different experiments in triplicate.
Statistical differences were evaluated with one way
ANOVA followed by Tuckey T test. Differences were
considered as statistically significant when P-value was
equal or less than 0.05.
The four strains of L. salivarius showed a different
ability to modulate production of IFN-g and IL-12 in
THP-1 monocyte cells (Figure 1). Production of IFN-g
was greatly stimulated by strains LDR0723 and
CRL1528, while only slight increments were observed in
cells treated with BNL1059 and RGS1746. Significant
differences in IFN-g production were observed between
LDR0723 and BNL1059 and RGS1746 and between
CRL1528 and BNL1059 and RGS1746. All the four
strains stimulate production of IL-12, although at
Figure 1 Release of Th1 cytokines by THP-1 cells. Open bars:
IFN-g, Pointed bars: IL-12. Data are means of three experiments ±
SD *p < 0.05 vs LDR0723 and CRL1528; #: p < 0.05 vs LDR0723.
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different rate, with LDR0723 and CRL1528 inducing sig-
nificantly higher levels than BNL1059 and RGS1746.
With respect to unstimulated cells, BNL1059 and
RGS1746 led to an increment in production of IL-4 in
THP-1 cells, while diminished levels of IL-4 were observed
in LDR0723 and CRL1528 treated cells (Figure 2). Produc-
tion of IL-5 was stimulated by all the four strains, with sig-
nificant higher levels observed in BNL1059 and RGS1746
treated cells with respect to LDR0723 and CRL1528
strains (Figure 2).
Th1/Th2 ratios are shown in Figure 3. L. salivarius
strains LDR0723 and CRL1528 significantly moved Th1/
Th2 balance toward Th1 response, while BNL1059 and
RGS1746 led to a decrease of the Th1/Th2 ratio in
favour of pro-inflammatory cytokines.
Conclusions
Inflammation and immunity changes are generally criti-
cal for the development of nearly every complex
condition. Alterations in equilibrium between Th-1 and
Th-2 responses have been linked to the pathogenesis of
a wide variety of diseases such as IBD, IBS and allergies.
Different patterns of cytokines are involved in the
pathogenesis of these diseases and they may act in
opposite ways, as observed, for instance in IBD, where
Crohn’s disease lesion is related to a predominant acti-
vation of Th1-lymphocytes, while lesion of ulcerative
colitis is mainly driven by Th2 cytokines [6,7]. Knowl-
edge on the immune-mediated mechanisms in metabolic
scenario has markedly increased in the recent past, evi-
dencing the role that dietary components may have to
modulate immunity by enhancing or suppressing the
immune response. For instance, certain strains of pro-
biotics have been demonstrated to be able to modulate
the immune system by stimulating release of different
patterns of cytokines by different cells [8].
In this study, four strains of L. salivarius of human
origin were evaluated for their capabilities to influence
production of pro- and anti-inflammatory cytokines by
THP-1 cells. These cells were preferred to peripheral
blood monocytes (PBMC) since the use of a cell line
allowed us to standardize the assay, avoiding variability
due to the fact that PBMCs harvested by apparently
healthy subjects, may be influenced in their response by
intrinsic factors due to individual variability.
Our results showed that the observed effects on cyto-
kines’ release are strictly strain-specific, since strains of
the same species may modulate different patterns of
cytokines and thus they may have opposite effects in the
same condition. In fact, of the four strains of L. salivar-
ius tested in the study, two modulated cellular immunity
towards Th1, while the rest favoured a Th2 response. In
comparison to unstimulated cells, LDR0723 and
CRL1528 strains seemed to differ in their activity. In
fact, LDR0723 favoured production of IL-12 rather than
of IFN-g, while a more sustained increment in release of
IFN-g than of IL-12 was produced by CRL1528. An
increment in production of IL-12 levels was found also
in cells stimulated with BNL1059 and RGS1746, even
though they mainly oriented Th1/Th2 balance vs Th2.
IL-12 has an essential role in Th1 development, stimu-
lating activated T cells and NK cells to maximally pro-
duce IFN-g, and inhibiting IL-4 induced IgE production
by human PBMC in vitro [9]. In turn, IFN-g promotes
differentiation of naive Th lymphocytes (Th-0) towards
a Th-1 subsets, prevents proliferation of Th2 lympho-
cytes and acts on B cells to inhibit switching to IgE [10].
By contrast, BNL1059 and RGS1746 favoured produc-
tion of IL-4 which is known to promote production of
IgE [10] and, at a lesser extent, of IL-5 which specifically
controls production and activation and localization of
eosinophils, the major cause of tissue damage in atopic
disease [11]. Eosinophils have been recently shown to
Figure 2 Release of Th2 cytokines by THP-1 cells. Open bars:IL-4,
Pointed bars: IL-5. *p < 0.05 vs control (unstimulated cells). Data are
means of three experiments ± SD *p < 0.05 vs LDR0723 and
CRL1528.
Figure 3 Ratio between Th1 and Th2 responses. Data are means
of three experiments ± SD *p < 0.05 vs LDR0723 and CRL1528.
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constitutively store cytokine associated with Th1, Th2
and T regulatory responses, although a preferential Th2
cytokine secretion occurs in response to immuno-polar-
izing cytokine signal [12]. Lack of IL-4 has been recently
reported to modulate gut mucosal response in food
allergy through diminished expression of TNF-a mRNA,
increased Th1 IFN-g, IL-12p40 regulatory cytokines,
thus demonstrating their relevance in the control of
allergic inflammatory processes, especially in the intes-
tine [13]. Moreover, IL-12, IFN-g and IL-4 inhibit Th17
differentiation for human cells, which is the main
responsible rather than Th1 subsets for inflammation in
autoimmunity disorders [14,15]. IL-4 and IL-5 are
required to promote maturation of IgA, which appears,
in terms of humoral immunity at mucosal surfaces, to
combine properties of a neutralizing agent and of a
mucosal immunopotentiator inducing effector immune
response in a noninflammatory context favourable
to preserve local homeostasis of the gastrointestinal
tract [2].
The mechanism involved in the different immuno-sti-
mulatory ability of different strains of lactobacilli
belonging to the same species has not yet been fully elu-
cidated and its evaluation was beyond the aim of this
study. The differential immunostimulating property of
LTAs from bacteria with different pathogenicity seems
to correlate with content of D-alanine residues in the
repetitious chains of the LTA. In addition, a mutant of
Lactobacillus plantarum defective in D-alanylation of
LTA has been shown to reduce the release of inflamma-
tory cytokines from PBMC [16,17]. Therefore, composi-
tion in LTA might influence release of inflammatory
cytokines [16,17] as well as it has been shown that the
strain-dependent ability to promote synthesis of IL-12
may arise, at least in part, from the amount of peptido-
glycan present in gram-positive bacteria, and that integ-
rity of bacterial cell wall is essential for the induction of
IL-12 production [18,19]. Moreover it may be hypothe-
sized that other cellular components or bacterial pro-
ducts released by each single strain might be involved.
In the present study only four cytokines were assessed.
However, they are representative of Th1 or Th2
responses and have been often used to evaluate the
effect of lactobacilli and other bacteria on immune sys-
tem [20-22].
In conclusion data obtained in this study evidenced
that strains of the same species of Lactobacillus exhib-
ited different modulation of immune response towards
Th1 or Th2. For this reason, assessment of candidate
probiotic strains for their immunomodulatory properties
seems to be of notable importance to assure safety of
their use and efficacy in treatment of immune-mediated
diseases.
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